These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15632369)

  • 1. Medicare demonstration projects acknowledge evidence-based medicine in cancer care.
    Twombly R
    J Natl Cancer Inst; 2005 Jan; 97(1):6-7. PubMed ID: 15632369
    [No Abstract]   [Full Text] [Related]  

  • 2. PET coverage extended. Medicare won't stop covering post-treatment scans.
    Zigmond J
    Mod Healthc; 2013 Jun; 43(24):24. PubMed ID: 23875236
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare to cover brain scans.
    McGregor J
    Provider; 2005 Jan; 31(1):41-2. PubMed ID: 15757071
    [No Abstract]   [Full Text] [Related]  

  • 4. CMS and PET for solid tumors.
    Cannon H
    J Nucl Med; 2008 Dec; 49(12):23N. PubMed ID: 19038994
    [No Abstract]   [Full Text] [Related]  

  • 5. The National Oncologic PET Registry: lessons learned for coverage with evidence development.
    Tunis S; Whicher D
    J Am Coll Radiol; 2009 May; 6(5):360-5. PubMed ID: 19394577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice-based evidence of the beneficial impact of positron emission tomography in clinical oncology.
    Larson SM
    J Clin Oncol; 2008 May; 26(13):2083-4. PubMed ID: 18362363
    [No Abstract]   [Full Text] [Related]  

  • 7. CMS final decision on PET in solid tumors.
    J Nucl Med; 2013 Aug; 54(8):11N. PubMed ID: 23908268
    [No Abstract]   [Full Text] [Related]  

  • 8. Coverage may expand, but ... proposal on PET scans may not increase use.
    Rhea S
    Mod Healthc; 2009 Jan; 39(3):12. PubMed ID: 19209483
    [No Abstract]   [Full Text] [Related]  

  • 9. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA
    J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can we tell if PET imaging for cancer is cost effective?
    Mac Manus MP; Hicks RJ
    Lancet Oncol; 2010 Aug; 11(8):711-2. PubMed ID: 20688268
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implications.
    Squires MH; Staley CA; Knechtle W; Winer JH; Russell MC; Perez S; Sweeney JF; Maithel SK; Staley CA
    Ann Surg Oncol; 2015 May; 22(5):1739-45. PubMed ID: 25249258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Financial toxicity' looms as cancer combinations proliferate.
    Morrison C
    Nat Biotechnol; 2015 Aug; 33(8):783-4. PubMed ID: 26252117
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The price tag on progress--chemotherapy for colorectal cancer.
    Schrag D
    N Engl J Med; 2004 Jul; 351(4):317-9. PubMed ID: 15269308
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial Toxicity.
    Nogueira LA; Lenhani BE; Tomim DH; Kalinke LP
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):289-293. PubMed ID: 32102501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What drives diffusion of new cancer therapies?
    Schmidt C
    J Natl Cancer Inst; 2015 Jun; 107(6):djv162. PubMed ID: 26032609
    [No Abstract]   [Full Text] [Related]  

  • 17. Limited funding. Plan for PET scans draws docs' ire.
    Lee J
    Mod Healthc; 2013 Apr; 43(13):12. PubMed ID: 24006701
    [No Abstract]   [Full Text] [Related]  

  • 18. Episode-based payment for cancer care: a proposed pilot for Medicare.
    Bach PB; Mirkin JN; Luke JJ
    Health Aff (Millwood); 2011 Mar; 30(3):500-9. PubMed ID: 21383369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Completion of therapy by Medicare patients with stage III colon cancer.
    Gibbs P; McLaughlin S; Skinner I; Jones I; Hayes I; Chapman M; Johns J; Lim L; Faragher I
    J Natl Cancer Inst; 2006 Nov; 98(21):1582. PubMed ID: 17077360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cancer chemotherapy in DPC].
    Kubota T
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1174-8. PubMed ID: 15332539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.